Clinical Trials in New York

Showing 20521-20540 of 22,668 trials

Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removed

NCT00006006

Phase II trial to study the effectiveness of thalidomide plus interferon alfa in treating patients who have progressive liver cancer that cannot be surgically removed. Thalidomide may stop the growth of liver cancer by stopping blood flow to the tumor. Interferon alfa may interfere with the growth of the cancer cells. Combining thalidomide and interferon alfa may kill more tumor cells.

Liver Cancer

National Cancer Institute (NCI)38 participantsStarted Aug 2000

New York, New York, United States • New York, New York, United States

COMPLETEDPhase 1/2< 1 mile

BMS-275291 in Treating Patients With HIV-Related Kaposi's Sarcoma

NCT00024024

Phase I/II trial to study the effectiveness of BMS-275291 in treating patients who have HIV-related Kaposi's sarcoma. Drugs such as BMS-275291 may stop the growth of Kaposi's sarcoma by stopping blood flow to the tumor.

Sarcoma

National Cancer Institute (NCI)59 participantsStarted Aug 2001

Chicago, Illinois, United States • St Louis, Missouri, United States • New York, New York, United States

COMPLETEDPhase 1< 1 mile

Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors

NCT00004242

Phase I trial to study the effectiveness of combination chemotherapy in treating patients who have metastatic or unresectable solid tumors. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.

Unspecified Adult Solid Tumor, Protocol Specific

National Cancer Institute (NCI)30 participantsStarted Oct 1999

New York, New York, United States • The Bronx, New York, United States

Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removed

BMS-275291 in Treating Patients With HIV-Related Kaposi's Sarcoma

Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors

Find Trials by Condition in New York

A Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Study Comparing Sirolimus With Cyclosporine in a Calcineurin Inhibitor (CNI)-Free Regimen in Kidney Transplant Recipients

Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia

ICATA Asthma Mechanistic Study

Fenretinide in Treating Children With Solid Tumors

Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma

Prescription Opioid Addiction Treatment Study (POATS)

Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer

Cortisol Augmentation of a Psychological Treatment in Warfighters With Post Traumatic Stress Disorder (PTSD)

Study Comparing Bifeprunox to Risperidone in Treatment of Outpatients With Schizophrenia With Weight as Primary Endpoint

Aminocamptothecin in Treating Patients With Refractory or Recurrent Hodgkin's Disease or Non-Hodgkin's Lymphoma

PolyethyleneGlycol3350 Laxative vs Placebo in Constipated Children

Sofia RSV FIA Field Study

An Open Label Study of Chronic Polyethyleneglycol3350 Use in Constipated Patients

Study Evaluating Levonorgestrel/Ethinyl Estradiol (LNG/EE) in PMS

HalfLytely Bowel Prep System for Colonoscopy

A Study of RoActemra/Actemra (Tocilizumab) in Patients With Ankylosing Spondylitis Who Have Failed Treatment With NSAIDs